MentionFox
Home › funding signals › AecorBio Inc.
Form D · on the record

AecorBio Inc. — $2.53M Form D filing, November 2025

AecorBio Inc. filed a Form D with the Securities and Exchange Commission on 2025-11-12.

AecorBio Inc. filed a Form D notice of an exempt securities offering with the SEC on November 12, 2025. The filing reports $2.53M sold. Its industry group is Biotechnology. It names Bomi Framroze (Executive Officer, Director) (SEC Form D, November 12, 2025).

125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

5 more Biotechnology raises in California, November 2025 ↓

Is this your company?

Key facts

Run the free check on AecorBio Inc. →

Sell to companies like AecorBio Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

AecorBio Inc.

New Form D on file · 2025-11-12 · the record

$2.53M
raise on the record
D
filing
20
investors in
CALIFORNIA
based
Open the record →

What the record says

FilingForm D
Filed2025-11-12
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
Year formed2023
BasedMENLO PARK, CALIFORNIA
CIK2096383
Accession0002096383-25-000001

Pitching, partnering or investing alongside them? See who really runs and owns AecorBio Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind AecorBio Inc., from the filings we hold.

More raises like this

Biotechnology raises by companies based in California, filed in November 2025, largest first.

What do you want to do with AecorBio Inc.?

Get the full cited report on AecorBio Inc.

What the filing shows about AecorBio Inc.

  • 20 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on AecorBio Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives AecorBio Inc.'s address as 1455 Adams Drive, Suite 2043, Menlo Park, CA 94025.

What the filing says

  • Offered: $2,532,988. Sold: $2,532,988. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 20 had already invested. (filing)
  • Date of first sale: August 16, 2025. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on AecorBio Inc. See pricing

Is AecorBio Inc. a real, registered company?

AecorBio Inc. is a registered filer with the SEC (CIK 2096383) and has filed since 2025-11-12. 1 filing is on record, the latest on 2025-11-12.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs AecorBio Inc.?

AecorBio Inc.'s Form D of 2025-11-12 names Bomi Framroze as its officers, directors or promoters.

How much has AecorBio Inc. raised?

Its new offerings report $2.53M sold across 1 offering, as its own filings state.

Biotechnology · by week
This raise, $2.53M, filed week of Nov 10

Trailing twelve months. 764 filings in Biotechnology, totalled by week. The dot is this raise, $2.53M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on AecorBio Inc.?

What the filing shows about AecorBio Inc.

  • 20 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on AecorBio Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on AecorBio Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind AecorBio Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for AecorBio Inc.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

AecorBio Inc.: Raised $2.53M, Form D filed 2025-11-12
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/aecorbio-inc-form-d-25000001
Last updated 2026-10-29
Primary record: SEC filing 1 · SEC filing 2
AecorBio Inc. raised $2.53M — SEC Form D filing, November 2025. MentionFox, 2026-10-29. https://mentionfox.com/funding/aecorbio-inc-form-d-25000001